Observational studyBMJ open2020

Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme.

Kamlesh Khunti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.